Stock Market News 2025-11-13
936 news published.
Market movers: major earnings and guidance
The Walt Disney Company (DIS) reported fourth‑quarter and full‑year fiscal 2025 results; investors continue to parse Disney+ subscriber trends and theme‑park margins for clues on the company's longer‑term market outlook.
Applied Materials (AMAT) released fourth‑quarter and FY25 results, a key read for chip‑equipment demand and the near‑term semiconductor capital‑spend cycle.
Stantec (STN) reported strong Q3 results, delivering over 17% growth in adjusted EPS — a notable beat for engineering and construction peers where backlog and margin leverage matter.
Nu Holdings Ltd. (NU) released third‑quarter 2025 results, an important snapshot for fintech growth and cross‑border digital banking trends that influence revenue mix and credit costs.
Globant (GLOB) reported third‑quarter 2025 financial results, an update relevant to digital‑services peers as demand mix and margin leverage remain focal points for guidance.
Corporate finance, capital markets and strategic investments
Brookfield Asset Management (BAM) priced $600 million of notes due 2030 and $400 million due 2036, a sizable debt raise that highlights portfolio financing strategies across real assets and can affect funding costs for large infrastructure plays.
GoPro (GPRO) founder and CEO Nicholas Woodman made a reported personal investment in the company, a signal that may shore up investor confidence and alter short‑term float dynamics.
Figure Technology Solutions (FIGR) filed a confidential draft registration for a proposed public offering of tokenized stock (details), an example of blockchain‑native capital markets experiments that investors will monitor for regulatory and execution risk.
Blue Ridge Bankshares (BRBS) announced the termination of a consent order, a regulatory clearance that can materially change capital and operational flexibility for regional banks.
M&A, restructuring and notice items
Blackstone (BX)'s energy arm announced a $1.2 billion investment to build a natural gas power facility in West Virginia, underscoring private capital flows into transition assets.
Cognizant (CTSH) is buying 3Cloud from Gryphon Investors in a deal that expands its cloud‑services footprint; see the transaction details.
CyberArk (CYBR) shareholders approved the company's acquisition by Palo Alto Networks — see the vote details — clearing a major consolidation in enterprise security.
Biotech, regulatory and trial updates
Kura Oncology (KURA) and Kyowa Kirin announced FDA approval of KOMZIFTI™ (ziftomenib), the first once‑daily targeted therapy for certain NPM1‑mutated AML patients — a clear commercial inflection.
Gilead Sciences (GILD) reported its investigational single‑tablet regimen met the primary endpoint in the Phase 3 ARTISTRY‑1 trial, an important readout for HIV treatment positioning.
enVVeno (NVNO) received an unfavorable FDA appeal ruling
Clean fuels, energy transition and industrials
LNZA announced the world's first commercial ethanol‑to‑jet fuel plant is now operational (details), a milestone for sustainable aviation fuel supply chains.
PG&E (PCG), Nissan, Fermata Energy and the Schatz Energy Research Center demonstrated vehicle‑to‑grid technology in California, underscoring grid‑edge flexibility and new revenue pathways for EVs.
Cloud, data centers and GPU capacity
La Rosa Holdings Corp. (LRHC) secured up to $1.25 billion in financing to accelerate AI data‑center infrastructure — underscoring capital intensity in GPU capacity buildouts.
CoreWeave (CRWV) announced a zero‑egress migration, lowering friction for multi‑cloud AI workflows and potentially reducing training costs.
Payments, logistics and autonomous delivery
DoorDash (DASH) and Coco Robotics expanded their pilot to Miami, broadening autonomous grocery and retail delivery — a test of unit economics and regulatory acceptance (details).
Notable corporate and small‑cap updates
Contango (CTGO) posted a record $25 million in income from operations and ended the quarter with $107 million cash, a liquidity metric investors will watch for distribution plans.
Tejon Ranch Co. (TRC) CEO issued a letter ahead of an investor engagement event (read), a reminder that land‑use plans and entitlement timelines remain valuation drivers.
Smaller filings and quarterly reports arrived from names like SAB BIO (SABS), Bio Green Med Solution (BGMS) and Stardust Power (SDST); these are noteworthy for sector watchers but carry more idiosyncratic risk than the larger items above.
Why these items matter to investors
Today's flow balances earnings beats, financing moves and regulatory verdicts that can shift sentiment quickly. Debt and note issuances from big managers like Brookfield (BAM) affect funding costs and signal confidence in asset strategies, while fintech results from Nu (NU) and engineering beats at Stantec (STN) provide fresh data on growth, margins and credit trends.
Corporate capital actions—from founder buys at GoPro (GPRO) to experimental filings like Figure's tokenized stock—change supply dynamics and raise regulatory questions for investors. Meanwhile, regulatory outcomes such as the enVVeno FDA appeal ruling show how single decisions can rerate small‑cap biotech risk.
Watch guidance revisions, balance‑sheet moves and any follow‑on filings or conference calls. Those will determine whether today's headlines translate into sustained sector rotation or short‑lived stock moves.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement